Stability and reproducibility comparisons between deep inspiration breath-hold techniques for left-sided breast cancer patients: A prospective study.
J Appl Clin Med Phys.
2023 May;24(5):e13906. doi: 10.1002/acm2.13906. Epub 2023 Jan 23. PubMed PMID:
36691339; PubMed Central PMCID:
PMC10161105.
Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients.
J Breast Cancer.
2023 Feb;26(1):14-24. doi: 10.4048/jbc.2023.26.e3. Epub 2023 Jan 25. PubMed PMID:
36762783; PubMed Central PMCID:
PMC9981985.
Feasibility and efficacy of active breathing coordinator assisted deep inspiration breath hold technique for treatment of locally advanced breast cancer.
J Appl Clin Med Phys.
2023 Feb;24(2):e13893. doi: 10.1002/acm2.13893. Epub 2022 Dec 31. PubMed PMID:
36585853; PubMed Central PMCID:
PMC9924105.
On the feasibility of improved target coverage without compromising organs at risk using online adaptive stereotactic partial breast irradiation (A-SPBI).
J Appl Clin Med Phys.
2023 Feb;24(2):e13813. doi: 10.1002/acm2.13813. Epub 2022 Nov 9. PubMed PMID:
36350273; PubMed Central PMCID:
PMC9924103.
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy.
NPJ Precis Oncol.
2023 Jan 24;7(1):11. doi: 10.1038/s41698-023-00348-1. PubMed PMID:
36693944; PubMed Central PMCID:
PMC9873388.
In Reply to Hannoun-Levi et al.
Int J Radiat Oncol Biol Phys.
2022 Jun 1;113(2):475-477. doi: 10.1016/j.ijrobp.2022.02.034. PubMed PMID:
35569485.
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial.
Int J Radiat Oncol Biol Phys.
2022 Jun 1;113(2):290-301. doi: 10.1016/j.ijrobp.2021.10.137. Epub 2021 Nov 11. PubMed PMID:
34774676; PubMed Central PMCID:
PMC9091061.
A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution.
Pract Radiat Oncol.
2022 May-Jun;12(3):e177-e182. doi: 10.1016/j.prro.2022.01.006. Epub 2022 Feb 10. PubMed PMID:
35150897.
Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer.
Int J Radiat Oncol Biol Phys.
2022 Mar 1;112(3):663-670. doi: 10.1016/j.ijrobp.2021.10.010. Epub 2021 Oct 25. PubMed PMID:
34710523.
A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer.
Int J Radiat Oncol Biol Phys.
2021 Sep 1;111(1):101-109. doi: 10.1016/j.ijrobp.2021.03.025. Epub 2021 Mar 19. PubMed PMID:
33753140.
Saliency-guided deep learning network for automatic tumor bed volume delineation in post-operative breast irradiation.
Phys Med Biol.
2021 Aug 27;66(17). doi: 10.1088/1361-6560/ac176d. PubMed PMID:
34298539; PubMed Central PMCID:
PMC8639319.
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer.
Int J Radiat Oncol Biol Phys.
2021 Jul 1;110(3):772-782. doi: 10.1016/j.ijrobp.2021.01.015. Epub 2021 Jan 18. PubMed PMID:
33476737.
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial.
Int J Radiat Oncol Biol Phys.
2020 Nov 1;108(3):697-706. doi: 10.1016/j.ijrobp.2020.05.025. Epub 2020 May 26. PubMed PMID:
32464155.
Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer.
Adv Radiat Oncol.
2020 May-Jun;5(3):516-521. doi: 10.1016/j.adro.2019.12.005. eCollection 2020 May-Jun. PubMed PMID:
32529149; PubMed Central PMCID:
PMC7276683.
Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial.
Support Care Cancer.
2020 Mar;28(3):1481-1489. doi: 10.1007/s00520-019-04957-0. Epub 2019 Jul 4. PubMed PMID:
31273506.
Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
Clin Cancer Res.
2019 Jul 15;25(14):4542-4551. doi: 10.1158/1078-0432.CCR-18-3004. Epub 2019 Apr 18. PubMed PMID:
31000589; PubMed Central PMCID:
PMC6635020.
A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.
Int J Radiat Oncol Biol Phys.
2019 May 1;104(1):83-89. doi: 10.1016/j.ijrobp.2019.01.072. Epub 2019 Jan 23. PubMed PMID:
30684664.
Deep-learning based surface region selection for deep inspiration breath hold (DIBH) monitoring in left breast cancer radiotherapy.
Phys Med Biol.
2018 Dec 12;63(24):245013. doi: 10.1088/1361-6560/aaf0d6. PubMed PMID:
30523967.
Prototype volumetric ultrasound tomography image guidance system for prone stereotactic partial breast irradiation: proof-of-concept.
Phys Med Biol.
2018 Mar 1;63(5):055004. doi: 10.1088/1361-6560/aaad1f. PubMed PMID:
29405123.
Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
Am J Clin Oncol.
2017 Dec;40(6):612-620. doi: 10.1097/COC.0000000000000207. PubMed PMID:
26165416.
Emphasis on Repair, Not Just Avoidance of Injury, Facilitates Prudent Stereotactic Ablative Radiotherapy.
Semin Radiat Oncol.
2017 Oct;27(4):378-392. doi: 10.1016/j.semradonc.2017.04.007. Review. PubMed PMID:
28865521.
Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiation.
Radiat Oncol.
2017 Sep 11;12(1):151. doi: 10.1186/s13014-017-0889-6. PubMed PMID:
28893302; PubMed Central PMCID:
PMC5594509.
Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
Med Dosim.
2017 Winter;42(4):341-347. doi: 10.1016/j.meddos.2017.07.002. Epub 2017 Jul 31. PubMed PMID:
28774760.
Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair.
Cancers (Basel).
2017 Jun 9;9(6). doi: 10.3390/cancers9060066. Review. PubMed PMID:
28598362; PubMed Central PMCID:
PMC5483885.
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Int J Radiat Oncol Biol Phys.
2017 May 1;98(1):91-100. doi: 10.1016/j.ijrobp.2017.01.032. PubMed PMID:
28587057; PubMed Central PMCID:
PMC5555369.
Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients.
Breast Cancer Res Treat.
2017 Feb;161(3):463-471. doi: 10.1007/s10549-016-4081-8. Epub 2016 Dec 22. PubMed PMID:
28005245.
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial.
Pract Radiat Oncol.
2017 Jan-Feb;7(1):e43-e49. doi: 10.1016/j.prro.2016.06.010. Epub 2016 Jun 24. PubMed PMID:
27637137.
Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.
Eur J Cancer.
2016 May;59:142-151. doi: 10.1016/j.ejca.2016.02.014. Epub 2016 Mar 29. PubMed PMID:
27035363.
Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome.
Springerplus.
2016;5:229. doi: 10.1186/s40064-016-1900-7. eCollection 2016. Review. PubMed PMID:
27026923; PubMed Central PMCID:
PMC4771672.
Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report.
Oncol Lett.
2016 Jan;11(1):713-716. doi: 10.3892/ol.2015.3940. Epub 2015 Nov 18. PubMed PMID:
26870272; PubMed Central PMCID:
PMC4727102.
Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy.
Cancer Med.
2015 Dec;4(12):1844-52. doi: 10.1002/cam4.554. Epub 2015 Oct 16. PubMed PMID:
26471467; PubMed Central PMCID:
PMC4940806.
Selective Efficacy of Temsirolimus on Bone Metastases in Chromophobe Renal Cell Carcinoma.
Clin Genitourin Cancer.
2015 Aug;13(4):e321-e323. doi: 10.1016/j.clgc.2014.12.007. Epub 2014 Dec 20. PubMed PMID:
25620636.
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
Clin Med Insights Oncol.
2015;9:61-3. doi: 10.4137/CMO.S27142. eCollection 2015. PubMed PMID:
26157340; PubMed Central PMCID:
PMC4489670.
Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus.
Cancer Biol Ther.
2015;16(5):657-61. doi: 10.1080/15384047.2015.1026506. PubMed PMID:
25800036; PubMed Central PMCID:
PMC4622024.
Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study.
Front Oncol.
2014;4:319. doi: 10.3389/fonc.2014.00319. eCollection 2014. PubMed PMID:
25505731; PubMed Central PMCID:
PMC4245005.
Intramedullary spinal cord hemorrhage after treatment with bevacizumab in a long-term survivor with metastatic non-small-cell lung cancer.
J Thorac Oncol.
2014 Aug;9(8):e60-1. doi: 10.1097/JTO.0000000000000172. PubMed PMID:
25157780.
DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy.
Int J Radiat Oncol Biol Phys.
2014 Jul 15;89(4):729-35. doi: 10.1016/j.ijrobp.2014.03.035. Epub 2014 May 24. PubMed PMID:
24867541; PubMed Central PMCID:
PMC4464555.
Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys.
2014 Jul 1;89(3):509-17. doi: 10.1016/j.ijrobp.2014.03.012. PubMed PMID:
24929162.
Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.
Cancer Biol Ther.
2014 Jun 1;15(6):699-706. doi: 10.4161/cbt.28554. Epub 2014 Mar 21. PubMed PMID:
24658086; PubMed Central PMCID:
PMC4049786.
Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months.
J Clin Oncol.
2013 Aug 10;31(23):e401-3. doi: 10.1200/JCO.2012.47.7455. Epub 2013 Jun 24. PubMed PMID:
23796996; PubMed Central PMCID:
PMC4878052.
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
Neoplasia.
2012 Dec;14(12):1203-12. doi: 10.1593/neo.121310. PubMed PMID:
23308052; PubMed Central PMCID:
PMC3540945.
Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer.
Cancer Res Treat.
2012 Jun;44(2):74-84. doi: 10.4143/crt.2012.44.2.74. Epub 2012 Jun 30. PubMed PMID:
22802745; PubMed Central PMCID:
PMC3394867.
Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.
Int J Radiat Oncol Biol Phys.
2008 May 1;71(1):237-46. doi: 10.1016/j.ijrobp.2007.12.049. Epub 2008 Mar 11. PubMed PMID:
18337021; PubMed Central PMCID:
PMC2441843.
Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
J Ultrasound Med.
2007 Jun;26(6):749-56. doi: 10.7863/jum.2007.26.6.749. PubMed PMID:
17526606.
Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules.
J Ultrasound Med.
2006 Dec;25(12):1507-17. doi: 10.7863/jum.2006.25.12.1507. PubMed PMID:
17121945.
Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging.
J Ultrasound Med.
2006 Apr;25(4):487-97. doi: 10.7863/jum.2006.25.4.487. PubMed PMID:
16567438.
Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.
Int J Radiat Oncol Biol Phys.
2006 Jan 1;64(1):38-46. doi: 10.1016/j.ijrobp.2005.02.008. PubMed PMID:
16377414.
Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys.
2005 Nov 15;63(4):1029-36. doi: 10.1016/j.ijrobp.2005.03.055. PubMed PMID:
15913910.
Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.
Lung Cancer.
2005 Nov;50(2):235-45. doi: 10.1016/j.lungcan.2005.05.020. Epub 2005 Jul 25. PubMed PMID:
16043262.
Receptor tyrosine kinase inhibitors as anti-angiogenic agents.
Curr Opin Investig Drugs.
2004 Jun;5(6):597-604. Review. PubMed PMID:
15242247.
What would you like to do?